% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Serra:55582,
      author       = {Serra, J.M. and Uhlenbruck, S. and Meulenberg, W. A. and
                      Buchkremer, H. P. and Stöver, D.},
      title        = {{N}ano-structuring in {S}olid {O}xide {F}uel {C}ells},
      journal      = {Topics in catalysis},
      volume       = {40},
      issn         = {1022-5528},
      address      = {Bussum},
      publisher    = {Baltzer},
      reportid     = {PreJuSER-55582},
      year         = {2006},
      note         = {Record converted from VDB: 12.11.2012},
      abstract     = {Healthy preterm infants fed formula with long-chain n-3
                      fatty acids (n-3 LCFAs) from marine oil have better early
                      visual acuity but lower plasma phosphatidylcholine (PC)
                      arachidonic acid (AA) and growth than infants fed formula
                      containing linolenic acid (LLA) as the sole n-3 fatty acid.
                      This randomized, double-blind trial was designed to study
                      the effects of a different source of n-3 LCFAs and a shorter
                      feeding interval on visual acuity (by Teller Acuity Card)
                      and growth of preterm infants (n = 59; 747-1275 g birth wt),
                      some of whom required long periods of supplemental oxygen
                      and developed bronchopulmonary dysplasia (BPD). Infants were
                      studied at 0, 2, 4, 6, 9, and 12 mo past term. Plasma PC AA,
                      and normalized weight, length, and head circumference were
                      not influenced by BPD or n-3 LCFAs except that n-3
                      LCFA-supplemented infants weighed less at 6 (P<0.05) and 9
                      (P<0.01) mo and had smaller head circumferences at 9 mo
                      (P<0.05). Compared with control infants, however, those fed
                      n-3 LCFAs had lower weight-for-length at 2, 6, 9, and 12 mo
                      (P<0.0003, P<0.0114, P<0.0008, and P<0.006, respectively).
                      n-3 LCFAs improved early (2-mo) but not later acuity among
                      infants without BPD (P<0.02). Regardless of diet, infants
                      with BPD had poorer grating acuity at 2 (P<0.0002) and 4
                      (P<0.04) mo but not thereafter.},
      keywords     = {Arachidonic Acid: blood / Arachidonic Acid: metabolism /
                      Body Height: drug effects / Body Height: physiology / Body
                      Weight: drug effects / Body Weight: physiology /
                      Bronchopulmonary Dysplasia: blood / Bronchopulmonary
                      Dysplasia: epidemiology / Bronchopulmonary Dysplasia:
                      physiopathology / Docosahexaenoic Acids: blood /
                      Docosahexaenoic Acids: pharmacology / Double-Blind Method /
                      Energy Intake: physiology / Fatty Acids, Omega-3:
                      administration $\&$ dosage / Fatty Acids, Omega-3:
                      pharmacology / Female / Food, Fortified / Humans / Incidence
                      / Infant, Newborn / Infant, Premature: blood / Infant,
                      Premature: growth $\&$ development / Infant, Premature:
                      physiology / Male / Phosphatidylcholines: blood /
                      Phosphatidylcholines: metabolism /
                      Phosphatidylethanolamines: blood /
                      Phosphatidylethanolamines: metabolism / Regression Analysis
                      / Visual Acuity: drug effects / Visual Acuity: physiology /
                      alpha-Linolenic Acid: blood / alpha-Linolenic Acid:
                      pharmacology / Fatty Acids, Omega-3 (NLM Chemicals) /
                      Phosphatidylcholines (NLM Chemicals) /
                      Phosphatidylethanolamines (NLM Chemicals) / Docosahexaenoic
                      Acids (NLM Chemicals) / alpha-Linolenic Acid (NLM Chemicals)
                      / Arachidonic Acid (NLM Chemicals) / J (WoSType)},
      cin          = {IWV-1 / JARA-ENERGY},
      ddc          = {540},
      cid          = {I:(DE-Juel1)VDB5 / $I:(DE-82)080011_20140620$},
      pnm          = {Rationelle Energieumwandlung / SOFC - Solid Oxide Fuel Cell
                      (SOFC-20140602)},
      pid          = {G:(DE-Juel1)FUEK402 / G:(DE-Juel1)SOFC-20140602},
      shelfmark    = {Chemistry, Applied / Chemistry, Physical},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:8615350},
      UT           = {WOS:000242689200013},
      doi          = {10.1007/s11244-006-0114-6},
      url          = {https://juser.fz-juelich.de/record/55582},
}